Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in Young School-Age Students Diagnosed Using the Moxo Test in the Context of the COVID-19 Pandemic
The global COVID-19 pandemic altered human functioning across many aspects for months, with its effects still felt today in various spheres of life, including education and health. It also held significance in the context of diagnosing developmental disorders in children and adolescents. This paper addresses the diagnosis of core symptoms of attention deficit hyperactivity disorder (ADHD) in younger school-age students before and after the end of the pandemic. It focuses on observed differences in students’ results in terms of attention, reaction time, impulsivity, and hyperactivity. Data was collected using an innovative tool, the d-CPT MOXO test. The study group consisted of students in the initial stage of education, corresponding to ages 7 to 10 in Poland. The findings indicate that COVID conditions did not play an unequivocally negative role in intensifying ADHD symptoms. Negative effects were most evident among 9-year-old girls and to a very limited extent among 7- and 8-year-old girls, as well as 7- and 9-year-old boys. Results also pointed to higher levels of cognitive functioning in MOXO test aspects under COVID conditions compared to pre-COVID conditions in both genders, though a broader range of ADHD symptom reduction associated with the pandemic was observed among boys than girls.